АЛИ Захид (GB),БАТЧЕР Кеннет Джон (GB),БАТТ Ричард Филип (GB),ФЕЛСТЕД Стефан Джон (GB),ГЛЭТТ Софи (GB),МАККЕРНАН Рат Митчелл (GB),ПЕЙНСЕР Мейниндер (GB)
申请号:
RU2014115733/04
公开号:
RU2014115733A
申请日:
2012.10.19
申请国别(地区):
RU
年份:
2015
代理人:
摘要:
1. 4- [2- (5-amino-1H-pyrazol-4-yl) -4-chlorophenoxy] -5-chloro-2-fluoro-N- (1,3-thiazol-4-yl) benzenesulfonamide or its a pharmaceutically acceptable salt for treating a disease associated with elevated levels of uric acid in the blood. 2. 4- [2- (5-amino-1H-pyrazol-4-yl) -4-chlorophenoxy] -5-chloro-2-fluoro-N- (1,3-thiazol-4-yl) benzenesulfonamide or a pharmaceutically acceptable thereof salt as defined in claim 1, wherein the disease associated with elevated levels of uric acid in the blood is hyperuricemia. 3. 4- [2- (5-amino-1H-pyrazol-4-yl) -4-chlorophenoxy] -5-chloro-2-fluoro-N- (1,3-thiazol-4-yl) benzenesulfonamide or a pharmaceutically acceptable thereof salt as defined in paragraph 1, where the disease associated with elevated levels of uric acid in the blood is gout. Use of 4- [2- (5-amino-1H-pyrazol-4-yl) -4-chlorophenoxy] -5-chloro-2-fluoro-N- (1,3-thiazol-4-yl) benzenesulfonamide or its pharmaceutically an acceptable salt for the manufacture of a medicament for the treatment of a disease associated with elevated levels of uric acid in the blood. 5. The use of claim 4, wherein the disease associated with elevated levels of uric acid in the blood is hyperuricemia. The use of claim 4, wherein the disease associated with elevated levels of uric acid in the blood is gout. A method for treating a disease associated with elevated levels of uric acid in the blood, in which a subject in need of such treatment is prescribed a therapeutically effective amount of 4- [2- (5-amino-1H-pyrazol-4-yl) -4-chlorophenoxy] - 5-chloro-2-fluoro-N- (1,3-thiazol-4-yl) benzenesulfonamide or a pharmaceutically acceptable salt thereof. 8. Combination of 4- [2- (5-amino-1H-pyrazol-4-yl) -4-chlorophenoxy] -5-chloro-2-fluoro-N- (1,3-thiazol-4-yl) benzenesulfonamide or its pharmaceutically is acceptable1. 4-[2-(5-Амино-1H-пиразол-4-ил)-4-хлорфенокси]-5-хлор-2-фтор-N-(1,3-тиазол-4-ил)бензолсульфонамид или его фармацевтически приемлемая соль для лечения заболевания, связанного с повышен